Literature DB >> 29869218

Genome-wide screening differential long non-coding RNAs expression profiles discloses its roles involved in OHSS development.

Haiyan Lin1, Yu Li1, Weijie Xing2, Qi Qiu1, Wenjun Wang1, Qingxue Zhang3.   

Abstract

OBJECTIVE: To screen differentially expressed lncRNAs involved in OHSS. OHSS is defined as ovarian hyperstimulation syndrome. It is characterized as enlarged ovary and increased vascular permeability.
DESIGN: Case-control study.
SETTING: University-affiliated hospital. PATIENT(S): Patients with OHSS high risk (n = 30) and low risk (n = 30) were included in this study. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): LncRNAs from women with OHSS high risk and low risk were used for high-throughput sequencing profiling. The eight most differentially expressed lncRNAs in granulosa cells were validated by semi-quantitative reverse transcription-polymerase chain reaction analysis. RESULT(S): A total of 23,815 lncRNAs were detected and 482 were differentially expressed (fold-change ≥2; p < 0.05, FDR value < 0.001), of which 205 were upregulated and 277 were downregulated. Lnc-SEC16B.1-6, lnc-SNURF-13, lnc-LGR6-6, and lnc-H2AFY2-2 were up-regulated, while lnc-BRD2-2, lnc-HSPA6-2, and lnc-CLIC6-5 were downregulated significantly in granulosa cells. These results were confirmed by qRT-PCR. KEGG pathways and Gene Ontology enrichment analysis revealed that several biological processes were significantly associated. Meanwhile, the lncRNA/miRNA interaction network was established according to ceRNA network model. CONCLUSION(S): Comprehensive expression screening identified eight novel lncRNAs associated with risk factors of OHSS process. Although it is unclear how these altered lncRNAs regulate the process of OHSS, our findings suggest these lncRNAs may be novel players in OHSS development.

Entities:  

Keywords:  Development; OHSS; lncRNA

Mesh:

Substances:

Year:  2018        PMID: 29869218      PMCID: PMC6086797          DOI: 10.1007/s10815-018-1199-0

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  33 in total

1.  Jugular vein thrombosis with severe local and systemic inflammation in a woman with ovarian hyperstimulation syndrome.

Authors:  Gabriella V Bedarida; Ullrich Hoffmann; Federico Tatò
Journal:  Thromb Haemost       Date:  2006-06       Impact factor: 5.249

Review 2.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

3.  Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome.

Authors:  María Cerrillo; Alberto Pacheco; Sara Rodríguez; Raúl Gómez; Francisco Delgado; Antonio Pellicer; Juan A Garcia-Velasco
Journal:  Fertil Steril       Date:  2011-01-26       Impact factor: 7.329

4.  MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome.

Authors:  Linlin Jiang; Jia Huang; Lin Li; Yaxiao Chen; Xiaoli Chen; Xiaomiao Zhao; Dongzi Yang
Journal:  J Clin Endocrinol Metab       Date:  2015-02-19       Impact factor: 5.958

Review 5.  Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline.

Authors: 
Journal:  Fertil Steril       Date:  2016-09-24       Impact factor: 7.329

Review 6.  Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.

Authors:  Annick Delvigne; Serge Rozenberg
Journal:  Hum Reprod Update       Date:  2002 Nov-Dec       Impact factor: 15.610

Review 7.  VEGF antagonist for the prevention of ovarian hyperstimulation syndrome: Current status.

Authors:  Nikita Naredi; Pankaj Talwar; K Sandeep
Journal:  Med J Armed Forces India       Date:  2012-09-11

8.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

9.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Authors:  Daehwan Kim; Geo Pertea; Cole Trapnell; Harold Pimentel; Ryan Kelley; Steven L Salzberg
Journal:  Genome Biol       Date:  2013-04-25       Impact factor: 13.583

10.  LncRNA lnc-RI regulates homologous recombination repair of DNA double-strand breaks by stabilizing RAD51 mRNA as a competitive endogenous RNA.

Authors:  Liping Shen; Qi Wang; Ruixue Liu; Zhongmin Chen; Xueqing Zhang; Pingkun Zhou; Zhidong Wang
Journal:  Nucleic Acids Res       Date:  2018-01-25       Impact factor: 16.971

View more
  3 in total

Review 1.  Long non-coding RNAs in ovarian granulosa cells.

Authors:  Jiajie Tu; Yu Chen; Zhe Li; Huan Yang; He Chen; Zhiying Yu
Journal:  J Ovarian Res       Date:  2020-06-05       Impact factor: 4.234

2.  Exosomal miR-27 negatively regulates ROS production and promotes granulosa cells apoptosis by targeting SPRY2 in OHSS.

Authors:  Kailu Liu; Weijie Yang; Mengting Hu; WenXiu Xie; Jingyu Huang; Meiting Cui; Xi He; Xiaowei Nie
Journal:  J Cell Mol Med       Date:  2021-02-27       Impact factor: 5.310

3.  Long noncoding RNA HCP5 participates in premature ovarian insufficiency by transcriptionally regulating MSH5 and DNA damage repair via YB1.

Authors:  Xiaoyan Wang; Xinyue Zhang; Yujie Dang; Duan Li; Gang Lu; Wai-Yee Chan; Peter C K Leung; Shidou Zhao; Yingying Qin; Zi-Jiang Chen
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.